Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Parkinson Disease
Interventions
DRUG

levodopa/carbidopa/entacapone

"On Day 1, subjects will be treated with levodopa/carbidopa/entacapone. Based on previous regimen. The dosage of levodopa/carbidopa/entacapone will be equal to the previous total daily dose of LD, and the frequency of administration of levodopa/carbidopa/entacapone is three or four times a day.~Levodopa/carbidopa/entacapone could be titrated in next 2 weeks according to the investigator's judgment, based on individual clinical response and tolerability.~After 2-week titration, the dose of levodopa/carbidopa/entacapone will remain as constant as possible to the end of study."

Trial Locations (1)

2I5004

RECRUITING

The Second Affiliated Hospital of Soochow University, Shanghai

All Listed Sponsors
lead

Second Affiliated Hospital of Soochow University

OTHER